Ustekinumab-Aauz 65219-0862
Product NDC
65219-0862- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 15, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761379
Need to source Ustekinumab-Aauz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ustekinumab | 45 mg/.5mL |
Drug Class
Interleukin-12 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-12 Antagonist [EPC]
Packaging Options(1)
1 SYRINGE in 1 CARTON (65219-862-01) / .5 mL in 1 SYRINGE